blood
mononuclear
cell
pbmc
cultur
deriv
healthi
control
strain
sarscov
use
studi
obtain
inocul
vero
cell
sputum
specimen
italian
patient
affect
sever
form
pneumonia
unknown
etiolog
histori
travel
vietnam
itali
march
pbmc
chosen
perform
experi
sever
studi
indic
sarscov
abl
infect
vitro
pbmc
determin
virusspecif
rna
product
order
make
comparison
perform
control
experi
cell
induc
produc
ifn
vesicular
stomat
vsv
newcastl
diseas
ndv
virus
use
virus
control
high
wellknown
capac
ifn
induct
briefli
human
pbmc
isol
buffi
coat
blood
donor
provid
blood
bank
sapienza
univers
rome
blood
collect
edta
tube
pbmc
separ
ficollhypaqu
gradient
sediment
pbmc
plate
plate
falcon
multiwel
bectondickinson
franklin
lake
nj
usa
infect
l
sarscov
moi
serumfre
medium
mem
sial
itali
supplement
l
glutamin
sial
itali
gml
gentamycin
sial
itali
adsorpt
h
excess
viru
inoculum
remov
cell
wash
phosphatebuff
salin
well
top
medium
plu
fetal
calf
serum
sial
itali
mlwell
cell
cultur
h
infect
sarscov
state
control
experi
vsv
ndv
moi
carri
safeti
precaut
cultur
supernat
collect
h
postinfect
pi
uv
irradi
h
inactiv
residu
infecti
viru
ifn
induct
analysi
cell
collect
h
viru
infect
frozen
subtyp
mrna
express
analysi
see
ifn
activ
determin
h
pi
evalu
reduct
cytopath
effect
bovin
madindarbi
bovin
kidney
cell
vsv
brief
cell
seed
well
plate
falcon
microtest
becton
dickinson
incub
threefold
serial
dilut
supernat
sampl
h
follow
incub
cell
challeng
vsv
moi
plate
incub
h
virusinduc
cytopath
effect
assess
microscop
examin
monolay
cell
stain
crystal
violet
ethanol
dye
taken
cell
elut
acet
acid
absorb
measur
nm
elisa
micropl
reader
ifn
concentr
express
invers
dilut
provid
cell
protect
viralinduc
cytopath
effect
figur
show
ifninduc
capac
sarscov
strain
seen
vsv
ndv
induc
higher
yield
ifn
activ
h
infect
pbmc
deriv
healthi
donor
sarscov
p
student
test
next
character
antivir
activ
supernat
pbmc
cultur
stimul
sarscov
analyz
product
use
differ
elisa
kit
human
elisa
kit
pbl
biomed
laboratori
tema
ricerca
itali
assay
carri
recommend
manufactur
instruct
result
show
sarscov
elicit
significantli
lower
product
compar
vsv
ndv
p
student
test
fig
b
c
except
amount
induc
h
sarscov
lower
significantli
induc
ndv
level
supernat
cultur
pbmc
infect
sarscov
show
signific
differ
compar
induc
vsv
ndv
fig
howev
trend
toward
lower
product
pbmc
infect
sarscov
compar
vsv
ndv
addit
observ
higher
level
supernat
pbmc
infect
sarscov
h
h
wherea
level
remain
rather
stabl
day
pi
next
investig
transcript
induct
main
subtyp
pbmc
infect
sarscov
realtim
revers
transcriptpolymeras
chain
reaction
rtpcr
taqman
use
abi
sequenc
detector
appli
biosystem
monza
itali
briefli
total
cellular
rna
extract
cell
use
phenol
guanidin
isothiocyan
reagent
trizol
gibco
brl
grand
island
ny
usa
follow
manufactur
instruct
rna
revers
transcrib
use
highcapac
cdna
archiv
kit
appli
biosystem
next
ad
follow
primer
pair
probe
subtyp
univers
pcr
master
mix
appli
biosystem
n
respect
final
volum
l
coamplif
glucuronidas
gene
assayondemand
appli
biosystem
use
control
total
amount
rna
extract
pbmc
rel
amount
transcript
normal
glucuronidas
mrna
calcul
use
arithmet
formula
ct
ct
accord
supplier
guidelin
appli
biosystem
pbmc
isol
healthi
donor
found
express
low
quantiti
subtyp
constitut
express
variabl
depend
examin
subtyp
specif
subtyp
valu
unstimul
pbmc
determin
use
equat
ct
accord
supplier
guidelin
rang
healthi
subject
result
also
show
first
time
knowledg
sarscov
vitro
infect
pbmc
lead
transcript
induct
sever
subtyp
induc
differ
extent
fig
particular
among
subtyp
detect
h
pi
major
transcript
follow
final
minor
transcrib
subtyp
differ
level
express
subtyp
measur
h
infect
sarscov
statist
signific
p
student
test
subtyp
reach
much
higher
level
h
pi
measur
control
h
pi
p
student
test
expect
signific
product
subtyp
pbmc
infect
vsv
ndv
h
well
h
observ
p
student
test
fig
b
c
interestingli
found
time
cours
h
infect
lower
level
subtyp
investig
transcrib
pbmc
infect
sarscov
compar
induc
vsv
ndv
ratio
valu
express
log
valu
subtyp
level
vsv
sarscov
pbmc
infect
variabl
mean
valu
h
rang
h
rang
analysi
perform
ndv
reveal
mean
valu
h
respect
express
subtyp
mrna
pbmc
healthi
donor
sar
coronaviru
cov
strain
infect
multipl
infect
experi
conduct
vsv
ndv
virus
b
c
h
infect
cell
harvest
rna
isol
use
trizol
reagent
taqman
revers
transcriptas
pcr
use
quantifi
subtyp
mrna
data
normal
glucuronidas
mrna
calcul
use
arithmet
formula
ct
accord
supplier
guidelin
ifn
q
p
compar
express
subtyp
uninfect
pbmc
control
use
student
test
p
compar
express
subtyp
uninfect
pbmc
control
h
pi
use
student
test
b
c
p
compar
express
subtyp
pbmc
infect
sarscov
use
student
test
find
consist
previou
observ
support
idea
express
level
subtyp
depend
kind
viral
stimulu
support
view
sarscov
poor
induc
subtyp
gain
new
insight
phenomenon
increas
subtyp
measur
pbmc
collect
healthi
donor
transfect
doublestrand
rna
synthet
analogu
polyriboinosinicpolyribocytidyl
acid
polyic
h
result
experi
shown
figur
seen
relev
amount
differ
subtyp
measur
cell
transfect
observ
indirectli
underlin
sarscov
infect
pbmc
accompani
low
induct
mrna
subtyp
suggest
tolllik
receptor
togeth
pattern
recognit
receptor
could
involv
signal
lead
express
type
ifn
pbmc
altogeth
data
present
studi
along
previou
result
demonstr
sarscov
weak
induc
potenti
limit
studi
includ
fact
compar
ifn
respons
sarscovinfect
pbmc
relev
human
viru
line
report
contrast
human
coronaviru
influenza
viru
littl
induct
sarscovinfect
macrophag
moreov
shown
sarscov
infect
primari
human
macrophag
associ
strong
induct
chemokin
without
associ
type
ifn
respons
compar
infect
find
consist
observ
sarscov
protein
prevent
ifn
induct
exist
particular
express
protein
sarscov
prevent
sendai
virusinduc
endogen
mrna
accumul
without
inhibit
dimer
ifn
regulatori
factor
protein
essenti
activ
promot
furthermor
express
promot
degrad
rna
transcript
host
endogen
mrna
lead
stronger
host
protein
synthesi
inhibit
addit
kopeckybromberg
et
al
found
sarscov
open
read
frame
orf
orf
n
protein
inhibit
express
suggest
like
highli
pathogen
virus
sarscov
genom
encod
one
protein
abl
inhibit
ifn
therefor
altogeth
result
may
help
explain
rapid
rise
viru
titer
initi
phase
sar
diseas
agreement
consider
report
sever
ifnstimul
gene
pkr
jakstat
signal
pathway
downregul
sar
patient
acut
sever
phase
compar
patient
convalesc
phase
howev
contrast
result
mani
result
obtain
vitro
experi
recent
demonstr
sarscov
induc
wide
rang
type
ifn
nuclear
transloc
phosphoryl
signal
transduc
activ
transcript
lung
macaqu
moreov
also
report
okabayashi
et
al
ifn
system
suppress
sarscov
infect
reason
discrep
still
unclear
sever
factor
taken
account
includ
differ
cell
type
use
investig
sarscov
capabl
induc
ifn
ii
method
employ
determin
ifn
induct
iii
time
sampl
collect
analysi
ifn
induct
respect
sarscov
infect
iv
type
viru
use
make
comparison
ifn
product
sarscov
infect
studi
requir
gain
better
understand
activ
ifn
system
sarscov
infect
importantli
result
studi
also
demonstr
lower
level
subtyp
investig
transcrib
pbmc
infect
sarscov
contrast
induc
vsv
ndv
addit
observ
sarscov
induc
characterist
profil
subtyp
product
gener
believ
transcript
differ
subtyp
modul
multipl
signal
pathway
depend
viru
type
cell
infect
howev
express
function
subtyp
infect
highli
pathogen
virus
poorli
investig
interestingli
hepat
c
viru
hcv
infect
report
associ
low
mrna
level
main
subtyp
express
liver
result
show
mrna
product
h
pi
lower
compar
subtyp
investig
induc
sarscov
contrari
level
higher
although
report
time
less
activ
infect
pbmc
either
herp
simplex
viru
differ
virus
paramixovirida
famili
well
known
differ
subtyp
possess
distinct
antivir
antiprolif
effect
vitro
vivo
report
potent
antivir
activ
murin
encephalomyel
viru
variou
human
cell
line
least
effici
agreement
koyama
et
al
demonstr
effect
subfamili
intracellular
hepat
c
viru
replic
light
find
fact
sarscov
induc
lower
level
compar
could
suggest
scenario
sar
viru
affect
select
express
specif
subtyp
biolog
activ
impair
express
specif
subtyp
caus
sarscov
could
contribut
main
immunopatholog
process
involv
sar
better
understand
sarscov
strategi
alter
subtyp
express
may
elucid
mechan
underli
virusinduc
airway
diseas
summari
data
togeth
previou
result
demonstr
sarscov
strain
induc
weak
ifn
respons
comparison
wellestablish
ifninduc
virus
vsv
ndv
phenomenon
also
describ
murin
hepat
coronaviru
close
relat
sarscov
interestingli
result
indic
sarscovinduc
activ
ifn
system
human
pbmc
associ
select
express
individu
subtyp
abund
subtyp
detect
h
pi
result
hope
make
contribut
studi
sar
pathogenesi
